A report by the Coalition of State Bioscience Institutes details the US life science industry’s workforce needs and what it must do to maintain its competitive advantage in the worldwide market.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
TEConomy/BIO. Investment, innovation and job creation in a growing US biosciences industry. https://www.bio.org/sites/default/files/TEConomy_BIO_2018_Report.pdf (2018).
TEConomy/BIO. The value of bioscience innovation in growing jobs and improving quality of life. https://www.bio.org/sites/default/files/BIO%202016_Report_FINAL_DIGITAL.pdf (2016).
CSBI. 2016 life science workforce trends report. http://califescienceworkforcetrends.org/2016-talent-report/ (2016).
CSBI. 2014 life science workforce trends report. http://califescienceworkforcetrends.org/2014-talent-report/ (2014).
CSBI & Booz & Company. Demand for Talent: Current & Projected Workforce Trends in the Life Science Industry (CSBI, 2013).
CSBI. 2018 life science workforce trends report. http://califescienceworkforcetrends.org/2018-talent-report/#fullReport (2018).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Lindburg, L., Bozinovic, L. & Susek, R. As the life science industry evolves, so do its talent needs. Nat Biotechnol 37, 481–483 (2019). https://doi.org/10.1038/s41587-019-0091-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-019-0091-5
This article is cited by
-
Assessing workforce needs for the emerging CAR-T cell therapy industry
Nature Biotechnology (2022)